Ameriprise’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.5M Sell
512,033
-73,644
-13% -$9.77M 0.02% 714
2025
Q4
$83.1M Sell
585,677
-28,900
-5% -$4.19M 0.02% 632
2025
Q3
$86.3M Buy
614,577
+171,332
+39% +$23.2M 0.02% 633
2025
Q2
$55.7M Buy
443,245
+127,535
+40% +$14.6M 0.01% 799
2025
Q1
$34.9M Sell
315,710
-97,769
-24% -$12.4M 0.01% 1018
2024
Q4
$56.4M Sell
413,479
-82,615
-17% -$10.2M 0.01% 776
2024
Q3
$57.2M Buy
496,094
+82,922
+20% +$11.4M 0.01% 791
2024
Q2
$56.9M Buy
413,172
+7,825
+2% +$1.07M 0.02% 743
2024
Q1
$55.9M Sell
405,347
-20,400
-5% -$2.79M 0.02% 758
2023
Q4
$56.1M Sell
425,747
-72,842
-15% -$8.38M 0.02% 729
2023
Q3
$56.1M Sell
498,589
-1,636
-0.3% -$172K 0.02% 695
2023
Q2
$47.2M Sell
500,225
-45,599
-8% -$4.46M 0.01% 786
2023
Q1
$55.2M Sell
545,824
-57,776
-10% -$6.01M 0.02% 704
2022
Q4
$72.1M Sell
603,600
-125,273
-17% -$14.7M 0.02% 588
2022
Q3
$77.4M Buy
728,873
+52,342
+8% +$5.31M 0.03% 541
2022
Q2
$65.9M Sell
676,531
-154,930
-19% -$14.3M 0.02% 622
2022
Q1
$77.9M Buy
831,461
+124,005
+18% +$10.5M 0.02% 624
2021
Q4
$60.2M Buy
707,456
+508,925
+256% +$46.8M 0.02% 760
2021
Q3
$19M Buy
198,531
+18,798
+10% +$1.78M 0.01% 1303
2021
Q2
$17.5M Sell
179,733
-23,180
-11% -$2.22M 0.01% 1460
2021
Q1
$19.7M Buy
202,913
+125,387
+162% +$13.1M 0.01% 1338
2020
Q4
$7.43M Sell
77,526
-258,713
-77% -$25M ﹤0.01% 1980
2020
Q3
$32.3M Sell
336,239
-42,078
-11% -$4.87M 0.01% 824
2020
Q2
$47.2M Buy
378,317
+13,178
+4% +$1.46M 0.02% 646
2020
Q1
$31.5M Buy
365,139
+25,895
+8% +$2.53M 0.02% 719
2019
Q4
$36.6M Buy
339,244
+325,055
+2,291% +$34M 0.02% 841
2019
Q3
$1.28M Sell
14,189
-12,475
-47% -$1.17M ﹤0.01% 2913
2019
Q2
$2.25M Sell
26,664
-415
-2% -$34.1K ﹤0.01% 2680
2019
Q1
$2.39M Buy
27,079
+23,064
+574% +$1.93M ﹤0.01% 2658
2018
Q4
$287K Sell
4,015
-222
-5% -$21.3K ﹤0.01% 3365
2018
Q3
$521K Buy
4,237
+233
+6% +$26.4K ﹤0.01% 3276
2018
Q2
$393K Sell
4,004
-17,802
-82% -$1.59M ﹤0.01% 3322
2018
Q1
$1.81M Sell
21,806
-84,079
-79% -$7.1M ﹤0.01% 2721
2017
Q4
$8.21M Buy
105,885
+79,244
+297% +$5.41M ﹤0.01% 1763
2017
Q3
$1.63M Buy
+26,641
New +$1.41M ﹤0.01% 2712
2016
Q4
Sell
-61,963
Closed -$3.14M 3920
2016
Q3
$3.14M Sell
61,963
-137,091
-69% -$6.83M ﹤0.01% 2324
2016
Q2
$9.05M Sell
199,054
-60,378
-23% -$2.78M 0.01% 1475
2016
Q1
$10.3M Buy
259,432
+33,980
+15% +$1.35M 0.01% 1394
2015
Q4
$12.8M Buy
225,452
+9,101
+4% +$463K 0.01% 1264
2015
Q3
$8.61M Buy
216,351
+65,814
+44% +$3.18M 0.01% 1581
2015
Q2
$7.19M Buy
+150,537
New +$6.38M ﹤0.01% 1868
2014
Q4
Sell
-385
Closed -$6K 4148
2014
Q3
$6K Buy
385
+5
+1% +$75 ﹤0.01% 5064
2014
Q2
$6K Buy
380
+260
+217% +$3.67K ﹤0.01% 4892
2014
Q1
$2K Sell
120
-13,750
-99% -$235K ﹤0.01% 5060
2013
Q4
$130K Sell
13,870
-4,860
-26% -$47.4K ﹤0.01% 3305
2013
Q3
$212K Sell
18,730
-76,553
-80% -$1.05M ﹤0.01% 3159
2013
Q2
$1.27M Buy
+95,283
New +$1.17M ﹤0.01% 2534

Other funds holding NBIX